StockComparison Logo
vs

GSK vs IBN

Comparison between GSK Plc (GSK, Company) and ICICI Bank Ltd (IBN, Company).

GSK is from the Healthcare sector, while IBN is from the Financial Services sector.

5-Year PerformanceIBN has outperformed GSK, delivering a return of +12.0% compared to +5.5%

GSK vs IBN - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
GSK
$105B
Winner
IBN
$105B
Max Drawdown
Winner
GSK
64.03%
IBN
86.33%
Sharpe Ratio
Winner
GSK
1.31
IBN
-0.66
5Y Beta
Winner
GSK
0.22
IBN
0.41
Industry
GSK
Drug Manufacturers - General
IBN
Banks - Regional
P/E Ratio
Winner
GSK
12.08
IBN
17.29
Forward P/E
GSK
21.51
Winner
IBN
17.36
PEG Ratio
Winner
GSK
0.10
IBN
0.53
Dividend Yield
Winner
GSK
3.51%
IBN
0.86%
5Y Dividends CAGR
GSK
1.34%
IBN
N/A
5Y EPS CAGR
GSK
4.65%
Winner
IBN
18.19%
Debt to Equity
GSK
106.74%
IBN
N/A
Free Cash Flow Yield
Winner
GSK
8.05%
IBN
-2.08%
P/S Ratio
GSK
3.13
Winner
IBN
0.05
P/B Ratio
GSK
4.36
Winner
IBN
2.70

GSK vs IBN - Historical Returns

Returns include dividend reinvestment.

1M
GSK
+9.53%
Winner
IBN
+16.67%
3M
GSK
-4.57%
Winner
IBN
+15.17%
6M
Winner
GSK
+9.90%
IBN
-1.65%
1Y
Winner
GSK
+44.44%
IBN
-11.49%
5Y(CAGR)
GSK
+5.46%
Winner
IBN
+12.03%
10Y(CAGR)
GSK
+4.70%
Winner
IBN
+16.76%
Max(CAGR)
GSK
+3.27%
Winner
IBN
+11.21%

GSK vs IBN - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGSKIBN
2026+9.90%-1.65%
2025+50.62%+0.73%
2024-6.27%+28.43%
2023+9.25%+9.55%
2022-32.73%+8.20%
2021+23.62%+37.45%
2020-17.52%-2.43%
2019+30.36%+44.62%
2018+9.29%+4.75%
2017-3.80%+43.94%
2016+1.52%+0.11%
2015+0.48%-33.23%
2014-14.73%+62.86%
2013+26.97%-17.14%
2012-0.75%+58.07%
2011+22.51%-47.59%
2010-3.72%+34.57%
2009+20.27%+85.60%
2008-21.93%-68.46%
2007-2.77%+47.15%
2006+6.93%+41.97%
2005+9.96%+47.93%
2004+5.08%+12.83%
2003+25.04%+178.06%
2002-22.83%+41.63%
2001-9.58%-23.81%
2000+5.67%-55.26%
1999-5.78%N/A

GSK vs IBN Drawdown Comparison

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The maximum drawdown for IBN was -86.08%, occurring on Mar 9, 2009. Recovery took 1772 trading sessions.

The current GSK drawdown is -10.85%. The current IBN drawdown is -13.63%.

RankGSKIBN
#1-50.11%
Apr 13, 2022 - Jan 6, 2026
-86.08%
Jan 10, 2008 - Jan 26, 2015
#2-49.64%
Apr 20, 2007 - Apr 18, 2012
-84.49%
Apr 7, 2000 - Dec 29, 2003
#3-45.23%
Apr 25, 2000 - Nov 11, 2005
-58.79%
Jan 27, 2015 - Jan 25, 2018
#4-32.56%
Jan 17, 2020 - Dec 10, 2021
-55.05%
Feb 12, 2020 - Feb 1, 2021
#5-27.97%
Mar 4, 2014 - Sep 3, 2019
-38.62%
Jan 2, 2004 - Nov 23, 2004
#6-26.98%
Nov 5, 1999 - Apr 11, 2000
-33.10%
Mar 1, 2006 - Oct 12, 2006
#7-18.61%
Feb 18, 2026 - Jun 2, 2026
-31.19%
Jan 26, 2018 - Mar 15, 2019
#8-14.45%
Jan 18, 2022 - Apr 7, 2022
-28.56%
Jul 19, 2007 - Oct 1, 2007
#9-10.52%
May 16, 2006 - Feb 13, 2007
-26.24%
Jan 12, 2022 - Aug 12, 2022
#10-10.48%
Oct 4, 2012 - Mar 22, 2013
-26.21%
Jul 23, 2025 - Mar 30, 2026
#11-8.45%
May 28, 2013 - Nov 1, 2013
-21.98%
Sep 30, 2005 - Dec 16, 2005
#12-8.43%
Apr 11, 2000 - Apr 25, 2000
-21.84%
Feb 8, 2007 - May 16, 2007
#13-8.16%
Nov 11, 2005 - Mar 8, 2006
-20.70%
Feb 16, 2021 - May 27, 2021
#14-7.54%
Feb 14, 2007 - Apr 16, 2007
-20.38%
Oct 31, 2007 - Jan 10, 2008
#15-7.37%
Jan 21, 2014 - Feb 13, 2014
-20.18%
Feb 28, 2005 - Jul 5, 2005

Correlation

Correlation between GSK and IBN is 0.73 which considered as a strong positive correlation - the stocks tend to move together.

0.73
-101

Dividend Comparison (2000 - 2026)

GSK vs IBN dividend yield comparison.

YearGSKIBN
20261.65%0.00%
20253.42%0.84%
20244.60%0.80%
20233.75%0.81%
20225.47%0.57%
20214.99%0.27%
20205.59%0.00%
20194.35%0.19%
20185.65%0.43%
20175.83%0.79%
20166.86%1.98%
20155.93%4.01%
20146.20%1.32%
20134.51%1.79%
20125.70%1.32%
20114.83%2.35%
20105.10%2.07%
20094.39%1.22%
20085.74%2.68%
20074.09%0.81%
20063.29%0.87%
20053.03%1.35%
20043.38%1.62%
20032.77%1.90%
20023.10%1.26%
20011.54%1.79%
20004.57%0.00%

Select Stocks to Compare